BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20979704)

  • 1. Characteristics of Klebsiella pneumoniae bacteremia in community-acquired and nosocomial infections in diabetic patients.
    Tsai SS; Huang JC; Chen ST; Sun JH; Wang CC; Lin SF; Hsu BR; Lin JD; Huang SY; Huang YY
    Chang Gung Med J; 2010; 33(5):532-9. PubMed ID: 20979704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection.
    Tsay RW; Siu LK; Fung CP; Chang FY
    Arch Intern Med; 2002 May; 162(9):1021-7. PubMed ID: 11996612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome.
    Panhotra BR; Saxena AK; Al-Ghamdi AM
    Saudi Med J; 2004 Dec; 25(12):1871-6. PubMed ID: 15711657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae.
    Lee JA; Kang CI; Joo EJ; Ha YE; Kang SJ; Park SY; Chung DR; Peck KR; Ko KS; Lee NY; Song JH
    Microb Drug Resist; 2011 Jun; 17(2):267-73. PubMed ID: 21388296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacteremia caused by Escherichia coli and Klebsiella pneumoniae producing extended-spectrum betalactamases: mortality and readmission-related factors].
    Perianes-Díaz ME; Novo-Veleiro I; Solís-Díaz K; Prolo-Acosta A; García-García I; Alonso-Claudio G
    Med Clin (Barc); 2014 May; 142(9):381-6. PubMed ID: 23735867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
    Kang CI; Kim SH; Bang JW; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
    J Korean Med Sci; 2006 Oct; 21(5):816-22. PubMed ID: 17043412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
    Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
    Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
    Lee CI; Lee NY; Yan JJ; Lee HC; Ko NY; Chang CM; Wu CJ; Chen PL; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2009 Aug; 42(4):303-9. PubMed ID: 19949753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Klebsiella pneumoniae bacteremia: community-acquired vs. nosocomial infections.
    Yang PY; Huang CC; Leu HS; Chiang PC; Wu TL; Tsao TC
    Chang Gung Med J; 2001 Nov; 24(11):688-96. PubMed ID: 11820649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for in-hospital mortality in patients with type 2 diabetes complicated by community-acquired Klebsiella pneumoniae bacteremia.
    Huang CH; Tsai JS; Chen IW; Hsu BR; Huang MJ; Huang YY
    J Formos Med Assoc; 2015 Oct; 114(10):916-22. PubMed ID: 26315482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcome of patients with community-onset Klebsiella pneumoniae bacteremia requiring intensive care.
    Tseng CP; Wu HS; Wu TH; Lin YT; Fung CP
    J Microbiol Immunol Infect; 2013 Jun; 46(3):217-23. PubMed ID: 22832028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
    Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
    Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and outcomes of Klebsiella pneumoniae bacteraemia in Hong Kong.
    Pau CK; Ma FF; Ip M; You JH
    Infect Dis (Lond); 2015 May; 47(5):283-8. PubMed ID: 25697339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of healthcare-associated and community-acquired Klebsiella pneumoniae bacteremia in Taiwan.
    Wu HS; Wang FD; Tseng CP; Wu TH; Lin YT; Fung CP
    J Infect; 2012 Feb; 64(2):162-8. PubMed ID: 22101080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
    Kim SH; Kwon JC; Choi SM; Lee DG; Park SH; Choi JH; Yoo JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    Ann Hematol; 2013 Apr; 92(4):533-41. PubMed ID: 23161391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nosocomial Klebsiella pneumoniae bacteraemia in adult cancer patients--characteristics of neutropenic and non-neutropenic patients.
    Lin YT; Liu CJ; Fung CP; Tzeng CH
    Scand J Infect Dis; 2011 Aug; 43(8):603-8. PubMed ID: 21539500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community-acquired bacteraemia.
    Lee HC; Chuang YC; Yu WL; Lee NY; Chang CM; Ko NY; Wang LR; Ko WC
    J Intern Med; 2006 Jun; 259(6):606-14. PubMed ID: 16704562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
    Chen YH; Yao WZ; Wu R; Zhou QT; Liu ZY; Zhang XW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):815-9. PubMed ID: 19080534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Wang SS; Lee NY; Hsueh PR; Huang WH; Tsui KC; Lee HC; Wu CJ; Chang CM; Huang CC; Huang CF; Ko WC
    J Microbiol Immunol Infect; 2011 Aug; 44(4):282-8. PubMed ID: 21524962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.